Core Viewpoint - Alexandria Real Estate Equities, Inc. has announced the pricing terms for its cash tender offers to purchase up to $952,202,784.40 of its outstanding senior notes, which include the 3.000% Senior Notes due 2051, 3.550% Senior Notes due 2052, and 4.000% Senior Notes due 2050 [1] Group 1: Tender Offers Details - The total consideration for each $1,000 principal amount of the notes validly tendered includes an early tender premium of $50.00 [1] - The tender offers are set to expire on February 25, 2026, but the company does not expect to accept any tenders after the early tender date of February 9, 2026, as the aggregate principal amount tendered reached the maximum tender amount [1] - The company will accept for payment all notes purchased in connection with the early tender date on February 12, 2026, which will also include accrued and unpaid interest [1] Group 2: Notes Information - The 3.000% Senior Notes due 2051 have an acceptance priority level of 1, with a total consideration of $656.22 and an aggregate principal amount tendered of $497,602,000 [1] - The 3.550% Senior Notes due 2052 have an acceptance priority level of 2, with a total consideration of $726.53 and an aggregate principal amount tendered of $524,594,000 [1] - The 4.000% Senior Notes due 2050 have an acceptance priority level of 3, with a total consideration of $790.86 and an aggregate principal amount tendered of $309,199,000 [1] Group 3: Company Overview - Alexandria Real Estate Equities, Inc. is a leading life science REIT, recognized for its pioneering role in the life science real estate niche since its founding in 1994 [2] - The company operates in key life science innovation cluster locations, including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City [2]

Core Viewpoint - Alexandria Real Estate Equities, Inc. has announced early results and an increase in the cash tender offers for its outstanding senior notes, indicating strong interest from investors and a strategic move to manage its debt effectively [1]. Group 1: Tender Offer Details - The company is conducting cash tender offers for three series of senior notes: 3.000% Senior Notes due 2051, 3.550% Senior Notes due 2052, and 4.000% Senior Notes due 2050 [1]. - As of February 9, 2026, the company received valid tenders totaling $497.602 million for the 2051 Notes, $524.594 million for the 2052 Notes, and $309.199 million for the 2050 Notes [1]. - The aggregate principal amount of all notes validly tendered by the Early Tender Date equals the Aggregate Maximum Tender Amount, leading the company to not expect any additional tenders after this date [1]. Group 2: Financial Management - The company is increasing the Aggregate Maximum Tender Amount to accept all validly tendered notes, demonstrating a proactive approach to managing its debt obligations [1]. - The determination of the Total Consideration for the tender offers will occur on February 10, 2026, indicating a structured timeline for the transaction [1]. - The company has engaged multiple financial institutions as Lead Dealer Managers and Co-Dealer Managers for the tender offers, showcasing a robust support structure for the transaction [1]. Group 3: Company Background - Alexandria Real Estate Equities, Inc. is a leading life science REIT, recognized for its pioneering role in the life science real estate sector since its founding in 1994 [2]. - The company operates in key life science innovation clusters, including Greater Boston, San Francisco Bay Area, and New York City, positioning itself as a significant player in the industry [2].

Core Viewpoint - Alexandria Real Estate Equities, Inc. has initiated cash tender offers to purchase up to $800,000,000 of its outstanding senior notes, which include 3.000% Senior Notes due 2051, 3.550% Senior Notes due 2052, and 4.000% Senior Notes due 2050 [1][4] Group 1: Tender Offer Details - The tender offers are open to all registered holders of the notes and are subject to the conditions outlined in the Offer to Purchase dated January 27, 2026 [4] - The company reserves the right to adjust the Aggregate Maximum Tender Amount at any time without extending withdrawal rights, except as required by law [4] - The total consideration for each series of notes will include an early tender premium of $50 per $1,000 principal amount if tendered by the Early Tender Date of February 9, 2026 [5][6] Group 2: Acceptance Priority and Conditions - Notes will be accepted based on their Acceptance Priority Levels, with higher priority notes being accepted before lower priority ones [7] - If the tender offers are fully subscribed by the Early Tender Date, notes tendered after this date will not be accepted for purchase [8] - The company's obligation to accept notes is contingent upon receiving at least $500,000,000 from other capital market financing transactions [9] Group 3: Financial and Operational Context - Alexandria Real Estate Equities, Inc. is a leading life science REIT, recognized for its role in developing collaborative ecosystems in key life science innovation clusters [11] - The company has been operational since 1994 and is noted for its long-standing presence in the life science real estate sector [11]